Review





Similar Products

t cell engagers tces  (Cullinan Oncology)
86
Cullinan Oncology t cell engagers tces
T Cell Engagers Tces, supplied by Cullinan Oncology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t cell engagers tces/product/Cullinan Oncology
Average 86 stars, based on 1 article reviews
t cell engagers tces - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
tce 5002  (Tocris)
94
Tocris tce 5002
Tce 5002, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tce 5002/product/Tocris
Average 94 stars, based on 1 article reviews
tce 5002 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
bcma cd3 tce  (Sanofi)
86
Sanofi bcma cd3 tce
Bcma Cd3 Tce, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bcma cd3 tce/product/Sanofi
Average 86 stars, based on 1 article reviews
bcma cd3 tce - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
june 2025 tce  (Boehringer Ingelheim)
86
Boehringer Ingelheim june 2025 tce
June 2025 Tce, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/june 2025 tce/product/Boehringer Ingelheim
Average 86 stars, based on 1 article reviews
june 2025 tce - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
tces  (Cullinan Oncology)
86
Cullinan Oncology tces
Tces, supplied by Cullinan Oncology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tces/product/Cullinan Oncology
Average 86 stars, based on 1 article reviews
tces - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
bispecific t cell engager tce expression plasmid  (Twist Bioscience)
86
Twist Bioscience bispecific t cell engager tce expression plasmid
Bispecific T Cell Engager Tce Expression Plasmid, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bispecific t cell engager tce expression plasmid/product/Twist Bioscience
Average 86 stars, based on 1 article reviews
bispecific t cell engager tce expression plasmid - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
tce  (Fisher Scientific)
86
Fisher Scientific tce
Tce, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tce/product/Fisher Scientific
Average 86 stars, based on 1 article reviews
tce - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
t cell engager tce blinatumomab  (Optum Inc)
86
Optum Inc t cell engager tce blinatumomab
Definition of the cohorts of interests, inclusion and exclusion criteria. From the Optum® COVID-19 data, subjects with active COVID-19 or who received <t>TCE</t> treatment <t>(blinatumomab)</t> were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.
T Cell Engager Tce Blinatumomab, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t cell engager tce blinatumomab/product/Optum Inc
Average 86 stars, based on 1 article reviews
t cell engager tce blinatumomab - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
tce cohort  (Optum Inc)
86
Optum Inc tce cohort
Definition of the cohorts of interests, inclusion and exclusion criteria. From <t>the</t> <t>Optum®</t> COVID-19 data, subjects with active COVID-19 or who received <t>TCE</t> treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.
Tce Cohort, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tce cohort/product/Optum Inc
Average 86 stars, based on 1 article reviews
tce cohort - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
trichloroethane 1 1 2 tce  (Janssen)
86
Janssen trichloroethane 1 1 2 tce
Definition of the cohorts of interests, inclusion and exclusion criteria. From <t>the</t> <t>Optum®</t> COVID-19 data, subjects with active COVID-19 or who received <t>TCE</t> treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.
Trichloroethane 1 1 2 Tce, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trichloroethane 1 1 2 tce/product/Janssen
Average 86 stars, based on 1 article reviews
trichloroethane 1 1 2 tce - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Definition of the cohorts of interests, inclusion and exclusion criteria. From the Optum® COVID-19 data, subjects with active COVID-19 or who received TCE treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.

Journal: Frontiers in Digital Health

Article Title: Guideline-based strategies to identify severe cytokine release syndrome in COVID-19 and cancer immunotherapy using large-scale electronic health records

doi: 10.3389/fdgth.2025.1625889

Figure Lengend Snippet: Definition of the cohorts of interests, inclusion and exclusion criteria. From the Optum® COVID-19 data, subjects with active COVID-19 or who received TCE treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.

Article Snippet: Using the Optum® de-identified COVID-19 EHR dataset, we isolated 2.5 million patients with active COVID-19 and 171 individuals treated with the T-cell Engager (TCE) blinatumomab.

Techniques: Isolation, Infection

Definition of the cohorts of interests, inclusion and exclusion criteria. From the Optum® COVID-19 data, subjects with active COVID-19 or who received TCE treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.

Journal: Frontiers in Digital Health

Article Title: Guideline-based strategies to identify severe cytokine release syndrome in COVID-19 and cancer immunotherapy using large-scale electronic health records

doi: 10.3389/fdgth.2025.1625889

Figure Lengend Snippet: Definition of the cohorts of interests, inclusion and exclusion criteria. From the Optum® COVID-19 data, subjects with active COVID-19 or who received TCE treatment (blinatumomab) were isolated. The first COVID-19 infection or TCE treatment was considered a triggering event. Subjects with missing information on gender or age were excluded. Subjects with pre-existing comorbidities that share traits with CRS at least 7 days before the triggering event were excluded. A significant number of COVID-19 patients had no reported data 30 days around the triggering event and were excluded. Patients diagnosed with Sepsis within 30 days after onset were also excluded. Three cohorts of interest were used for subsequent CRS case identification: ‘COVID-19 adult cohort’, ‘TCE adult cohort’ and ‘TCE pediatric cohort’.

Article Snippet: First, we do not know the origin of the TCE patients and we cannot exclude that this specific TCE cohort within the Optum COVID-19 data may derive from a study focusing on patients with specific comorbidities.

Techniques: Isolation, Infection